These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 24089324

  • 1. Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.
    Mukhopadhyay P, Rajesh M, Cao Z, Horváth B, Park O, Wang H, Erdelyi K, Holovac E, Wang Y, Liaudet L, Hamdaoui N, Lafdil F, Haskó G, Szabo C, Boulares AH, Gao B, Pacher P.
    Hepatology; 2014 May; 59(5):1998-2009. PubMed ID: 24089324
    [Abstract] [Full Text] [Related]

  • 2. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
    Mukhopadhyay P, Horváth B, Rajesh M, Varga ZV, Gariani K, Ryu D, Cao Z, Holovac E, Park O, Zhou Z, Xu MJ, Wang W, Godlewski G, Paloczi J, Nemeth BT, Persidsky Y, Liaudet L, Haskó G, Bai P, Boulares AH, Auwerx J, Gao B, Pacher P.
    J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
    [Abstract] [Full Text] [Related]

  • 3. Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury.
    Mota RA, Hernández-Espinosa D, Galbis-Martinez L, Ordoñez A, Miñano A, Parrilla P, Vicente V, Corral J, Yélamos J.
    Crit Care Med; 2008 Feb; 36(2):526-34. PubMed ID: 18091544
    [Abstract] [Full Text] [Related]

  • 4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ, Bourgeois M, Harbison RD.
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [Abstract] [Full Text] [Related]

  • 5. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition.
    Wang S, Shi XL, Feng M, Wang X, Zhang ZH, Zhao X, Han B, Ma HC, Dai B, Ding YT.
    Int Immunopharmacol; 2016 Sep; 38():238-45. PubMed ID: 27318789
    [Abstract] [Full Text] [Related]

  • 6. Poly(ADP-Ribose) Polymerase 1 Promotes Inflammation and Fibrosis in a Mouse Model of Chronic Pancreatitis.
    El-Hamoly T, Hajnády Z, Nagy-Pénzes M, Bakondi E, Regdon Z, Demény MA, Kovács K, Hegedűs C, Abd El-Rahman SS, Szabó É, Maléth J, Hegyi P, Virág L.
    Int J Mol Sci; 2021 Mar 30; 22(7):. PubMed ID: 33808340
    [Abstract] [Full Text] [Related]

  • 7. Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.
    Mukhopadhyay P, Horváth B, Kechrid M, Tanchian G, Rajesh M, Naura AS, Boulares AH, Pacher P.
    Free Radic Biol Med; 2011 Nov 01; 51(9):1774-88. PubMed ID: 21884784
    [Abstract] [Full Text] [Related]

  • 8. Dihydrokaempferol attenuates CCl4-induced hepatic fibrosis by inhibiting PARP-1 to affect multiple downstream pathways and cytokines.
    Huang H, Wei S, Wu X, Zhang M, Zhou B, Huang D, Dong W.
    Toxicol Appl Pharmacol; 2023 Apr 01; 464():116438. PubMed ID: 36841340
    [Abstract] [Full Text] [Related]

  • 9. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.
    Gariani K, Ryu D, Menzies KJ, Yi HS, Stein S, Zhang H, Perino A, Lemos V, Katsyuba E, Jha P, Vijgen S, Rubbia-Brandt L, Kim YK, Kim JT, Kim KS, Shong M, Schoonjans K, Auwerx J.
    J Hepatol; 2017 Jan 01; 66(1):132-141. PubMed ID: 27663419
    [Abstract] [Full Text] [Related]

  • 10. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation.
    Zerfaoui M, Errami Y, Naura AS, Suzuki Y, Kim H, Ju J, Liu T, Hans CP, Kim JG, Abd Elmageed ZY, Koochekpour S, Catling A, Boulares AH.
    J Immunol; 2010 Aug 01; 185(3):1894-902. PubMed ID: 20610652
    [Abstract] [Full Text] [Related]

  • 11. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Aug 01; 310(2):425-36. PubMed ID: 15075382
    [Abstract] [Full Text] [Related]

  • 12. Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1.
    Hu B, Wu Z, Hergert P, Henke CA, Bitterman PB, Phan SH.
    Am J Pathol; 2013 Jan 01; 182(1):71-83. PubMed ID: 23260200
    [Abstract] [Full Text] [Related]

  • 13. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.
    Cover C, Fickert P, Knight TR, Fuchsbichler A, Farhood A, Trauner M, Jaeschke H.
    Toxicol Sci; 2005 Mar 01; 84(1):201-8. PubMed ID: 15601672
    [Abstract] [Full Text] [Related]

  • 14. Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.
    Tiwari P, Khan H, Singh TG, Grewal AK.
    Neurochem Res; 2022 Jul 01; 47(7):1830-1852. PubMed ID: 35437712
    [Abstract] [Full Text] [Related]

  • 15. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
    Qin WD, Liu GL, Wang J, Wang H, Zhang JN, Zhang F, Ma Y, Ji XY, Li C, Zhang MX.
    Oncotarget; 2016 Jun 14; 7(24):35618-35631. PubMed ID: 27027354
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of poly(ADP-ribose) polymerase-1 attenuates the toxicity of carbon tetrachloride.
    Banasik M, Stedeford T, Strosznajder RP, Takehashi M, Tanaka S, Ueda K.
    J Enzyme Inhib Med Chem; 2011 Dec 14; 26(6):883-9. PubMed ID: 21395487
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury.
    Zhang Y, Wang C, Tian Y, Zhang F, Xu W, Li X, Shu Z, Wang Y, Huang K, Huang D.
    Am J Pathol; 2016 Dec 14; 186(12):3117-3130. PubMed ID: 27746183
    [Abstract] [Full Text] [Related]

  • 18. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5.
    Oumouna M, Datta R, Oumouna-Benachour K, Suzuki Y, Hans C, Matthews K, Fallon K, Boulares H.
    J Immunol; 2006 Nov 01; 177(9):6489-96. PubMed ID: 17056581
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury.
    Mota RA, Sánchez-Bueno F, Saenz L, Hernández-Espinosa D, Jimeno J, Tornel PL, Martínez-Torrano A, Ramírez P, Parrilla P, Yélamos J.
    Lab Invest; 2005 Oct 01; 85(10):1250-62. PubMed ID: 16127429
    [Abstract] [Full Text] [Related]

  • 20. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
    Pacher P, Szabó C.
    Cardiovasc Drug Rev; 2007 Oct 01; 25(3):235-60. PubMed ID: 17919258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.